Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Are all calcium antagonists equally effective for reducing reinfarction rate?

Messerli FH, Weiner DA.

Am J Cardiol. 1993 Oct 1;72(11):818-20. No abstract available.

PMID:
8213516
2.
4.

Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients.

Messerli FH, Hansen JF, Gibson RS, Schechtman KB, Boden WE.

J Hypertens. 2001 May;19(5):977-82.

PMID:
11393682
5.

Calcium antagonists and myocardial infarction.

Hansen JF.

Cardiovasc Drugs Ther. 1991 Aug;5(4):665-70. Review.

PMID:
1888690
7.
8.

[Calcium antagonists in the secondary prevention of myocardial infarction].

Lièvre M, Nony P.

Therapie. 1993 Nov-Dec;48 Spec No:677-83. French.

PMID:
8091354
9.

Are calcium antagonists cardioprotective?

Kendall MJ, Horton RC.

J R Coll Physicians Lond. 1985 Apr;19(2):85-9. Review. No abstract available.

PMID:
3889321
10.

Design of a multicenter, double-blind study to assess the effects of prophylactic diltiazem on early reinfarction after non-Q-wave acute myocardial infarction: diltiazem reinfarction study.

Pratt CM, Gibson R, Boden W, Theroux P, Strauss H, Gheorghiade M, Capone R, Crawford M, Schlant R, Arensberg D, et al.

Am J Cardiol. 1986 Nov 1;58(10):906-10.

PMID:
3535473
11.

[Comparative effects of three calcium antagonists (nifedipine, verapamil and diltiazem) on hemodynamics in recent myocardial infarction].

Sakai M, Ueda K, Nakahara K, Tsuchimochi H, Mutsushita S, Kuramoto K, Murakami M.

Kokyu To Junkan. 1985 Feb;33(2):159-64. Japanese. No abstract available.

PMID:
4001593
12.

[Comparative hemodynamic effects of nifedipine, verapamil and diltiazem in cases of acute myocardial infarction].

Yuan JN, Wang LH, Xu YY.

Zhonghua Nei Ke Za Zhi. 1986 Oct;25(10):591-3, 636. Chinese. No abstract available.

PMID:
3568839
13.

Diltiazem prevents reinfarction--but how does it work?

[No authors listed]

Am Pharm. 1986 Nov;NS26(11):15. No abstract available.

PMID:
3799452
14.

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.

Gibson RS, Boden WE, Theroux P, Strauss HD, Pratt CM, Gheorghiade M, Capone RJ, Crawford MH, Schlant RC, Kleiger RE, et al.

N Engl J Med. 1986 Aug 14;315(7):423-9.

PMID:
3526151
15.

Prevention of reinfarction subsequent to non-Q-wave infarction.

Roberts R, Gibson RS.

J Cardiovasc Pharmacol. 1989;13 Suppl 1:S36-46.

PMID:
2468975
16.
17.

Safety of heart rate-lowering calcium antagonists: lessons from controlled trials.

Messerli FH, Michalewicz L.

Am Heart J. 1997 Aug;134(2 Pt 2):S21-4. Review. No abstract available.

PMID:
9313620
18.

Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT)

Boden WE, van Gilst WH, Scheldewaert RG, Starkey IR, Carlier MF, Julian DG, Whitehead A, Bertrand ME, Col JJ, Pedersen OL, Lie KI, Santoni JP, Fox KM.

Lancet. 2000 May 20;355(9217):1751-6.

PMID:
10832825
20.

Temporal pattern of the effect of verapamil on myocardial reinfarction. DAVIT Study Group. Danish Verapamil Infarction Trial.

Sajadieh A, Hansen JF, Mortensen LS.

Cardiovasc Drugs Ther. 1998 Sep;12(4):405-8.

PMID:
9825187

Supplemental Content

Support Center